Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN952914 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Integrin alpha-8 / ITGA8 (AA 1032-1061), (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- Protein A column, followed by peptide affinity purification
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 1032-1061, C-Term
- Vial size
- 0.4 mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Integrin alpha8beta1 confers anoikis susceptibility to human intestinal epithelial crypt cells.
Integrin alpha8beta1 regulates adhesion, migration and proliferation of human intestinal crypt cells via a predominant RhoA/ROCK-dependent mechanism.
Molecular basis of the recognition of nephronectin by integrin alpha8beta1.
Genome-wide association study reveals genetic risk underlying Parkinson's disease.
Benoit YD, Larrivée JF, Groulx JF, Stankova J, Vachon PH, Beaulieu JF
Biochemical and biophysical research communications 2010 Aug 27;399(3):434-9
Biochemical and biophysical research communications 2010 Aug 27;399(3):434-9
Integrin alpha8beta1 regulates adhesion, migration and proliferation of human intestinal crypt cells via a predominant RhoA/ROCK-dependent mechanism.
Benoit YD, Lussier C, Ducharme PA, Sivret S, Schnapp LM, Basora N, Beaulieu JF
Biology of the cell 2009 Sep 14;101(12):695-708
Biology of the cell 2009 Sep 14;101(12):695-708
Molecular basis of the recognition of nephronectin by integrin alpha8beta1.
Sato Y, Uemura T, Morimitsu K, Sato-Nishiuchi R, Manabe R, Takagi J, Yamada M, Sekiguchi K
The Journal of biological chemistry 2009 May 22;284(21):14524-36
The Journal of biological chemistry 2009 May 22;284(21):14524-36
Genome-wide association study reveals genetic risk underlying Parkinson's disease.
Simón-Sánchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, Paisan-Ruiz C, Lichtner P, Scholz SW, Hernandez DG, Krüger R, Federoff M, Klein C, Goate A, Perlmutter J, Bonin M, Nalls MA, Illig T, Gieger C, Houlden H, Steffens M, Okun MS, Racette BA, Cookson MR, Foote KD, Fernandez HH, Traynor BJ, Schreiber S, Arepalli S, Zonozi R, Gwinn K, van der Brug M, Lopez G, Chanock SJ, Schatzkin A, Park Y, Hollenbeck A, Gao J, Huang X, Wood NW, Lorenz D, Deuschl G, Chen H, Riess O, Hardy JA, Singleton AB, Gasser T
Nature genetics 2009 Dec;41(12):1308-12
Nature genetics 2009 Dec;41(12):1308-12
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
